These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21611981)

  • 1. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
    Winkelman JW; Bogan RK; Schmidt MH; Hudson JD; DeRossett SE; Hill-Zabala CE
    Mov Disord; 2011 Sep; 26(11):2065-72. PubMed ID: 21611981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
    Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
    Chen D; Lal R; Zomorodi K; Atluri H; Ho J; Luo W; Tovera J; Bonzo D; Cundy K
    Clin Ther; 2012 Feb; 34(2):351-362.e3. PubMed ID: 22325733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
    Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
    Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin enacarbil for treatment of restless legs syndrome in adults.
    Hayes WJ; Lemon MD; Farver DK
    Ann Pharmacother; 2012 Feb; 46(2):229-39. PubMed ID: 22298601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
    VanMeter SA; Kavanagh ST; Warren S; Barrett RW
    CNS Drugs; 2012 Sep; 26(9):773-80. PubMed ID: 22849331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
    Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
    Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for restless legs syndrome.
    Winkelman JW; Jaros MJ
    Sleep Med; 2018 Aug; 48():1-7. PubMed ID: 29807228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.
    Lee DO; Ziman RB; Perkins AT; Poceta JS; Walters AS; Barrett RW;
    J Clin Sleep Med; 2011 Jun; 7(3):282-92. PubMed ID: 21677899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
    Bogan RK; Lee DO; Buchfuhrer MJ; Jaros MJ; Kim R; Shang G
    Ann Med; 2015 May; 47(3):269-77. PubMed ID: 25874578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
    Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.
    Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin Enacarbil: A Review in Restless Legs Syndrome.
    Kim ES; Deeks ED
    Drugs; 2016 May; 76(8):879-87. PubMed ID: 27146056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 52-week study of gabapentin enacarbil in restless legs syndrome.
    Ellenbogen AL; Thein SG; Winslow DH; Becker PM; Tolson JM; Lassauzet ML; Chen D
    Clin Neuropharmacol; 2011; 34(1):8-16. PubMed ID: 21242741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.
    Bogan RK; Bornemann MA; Kushida CA; Trân PV; Barrett RW;
    Mayo Clin Proc; 2010 Jun; 85(6):512-21. PubMed ID: 20511481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748).
    Zhang L; Rainka M; Freeman R; Harden RN; Bell CF; Chen C; Graff O; Harding K; Hunter S; Kavanagh S; Laurijssens B; Schwartzbach C; Warren S; McClung C
    J Pain; 2013 Jun; 14(6):590-603. PubMed ID: 23602345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac repolarization with Gabapentin enacarbil in a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
    Davy M; Upward J; Arumugham T; Twomey C; Chen C; Stier B
    Clin Ther; 2013 Dec; 35(12):1964-74. PubMed ID: 24290737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.